Accurate Symptom Reporting

Improve data accuracy: Train subjects to accurately report symptoms

Industry research reveals that 20% to 30% of patients enrolled in a pain trial are unable to report their pain accurately. WCG Analgesic Solutions’ validated Accurate Symptom Reporting training gives patients the skills they need to accurately and reliably assess their symptoms.

The increase in patient-reported clinical outcomes also increases risk to the quality of your data and can lead to a failed study.  If the success of your trial depends on patient-reported data, you need WCG Analgesic Solutions’ Accurate Symptom Reporting training services.

Training patients to accurately report their symptoms is often overlooked and can result in critically high variability and a decrease in observed effect size, adding to cost and delay in your development program.

Why Accurate Symptom Reporting works 

WCG Analgesic Solutions offers a proven, validated and industry-leading training program on symptom reporting. Developed from our heritage in measuring pain, the Accurate Symptom Reporting program trains patients to assess and report their symptoms more accurately and consistently. This reduces placebo response, reduces variability, and improves assay sensitivity

Teaching patients to be more introspective about their own bodies enables them to report symptoms more accurately. WCG Analgesic Solutions’ Accurate Symptom Reporting training essentially inoculates subjects against the external cues that diminish the signal to noise in your data.

Ready to inoculate your subjects? Schedule a consult today.

Accurate Symptom Reporting is Powered by WCG Analgesic Solutions

As precision medicine advances, ensuring data quality has become a tremendous challenge, especially in CNS trials. Missed signals, measurement errors and, of course, placebo response risk undermining them.

The team at WCG Analgesic Solutions has the people, processes and technology to overcome these challenges. Our world-class consulting, monitoring, risk-assessment tools, training and analytics services identify and mitigate the errors that put your clinical trial at risk.

A data-driven strategy to improve the signal-to-noise ratio

WCG Analgesic Solutions advises research sponsors on protocol design and development, regulatory and FDA submissions, and signal-to-noise optimization. Combining deep subject matter expertise with unmatched experience in data-quality risk assessment, measurement-error reduction and data surveillance, we offer an array of data-driven solutions:

Data-Quality Risk Assessment

Our team of experts will review your study’s protocol and identify a systematic approach to assessment and planning to detect errors early and reduce measurement error in a study.

Measurement-Error Reduction

Our evidence-based Accurate Pain Reporting and Placebo Response Reduction training mitigate variance in pain reporting and reduce placebo response in pain clinical trials.

Abuse-Risk Detection

We developed MADDERS® (Misuse, Abuse, and Diversion Drug Event Reporting System) in collaboration with the FDA-ACTTION initiative to meet the need for a standardized approach to quantifying abuse potential in investigational therapeutics.

Data Surveillance

Our Quantitative Data Surveillance System (QDSS) utilizes statistical process control to monitor clinical trials. This approach helps identify and correct issues at the subject, site and trial levels, sponsors to maximize assay and endpoint sensitivity as they meet scientific and regulatory expectations for data quality.

Explore Accurate Symptom Reporting for your study

Complete the form to request a schedule a consultation. We’ll assess your needs, review our training service and demonstrate how WCG can transform symptom reporting for your study.